Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype
- PMID: 1656083
- PMCID: PMC250261
- DOI: 10.1128/JVI.65.11.5968-5974.1991
Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype
Abstract
The neutralization epitopes of the VP7 of human rotavirus RV-4 were studied by using five neutralizing mouse monoclonal antibodies to select virus variants resistant to neutralization by each of the antibodies. Antibody resistance patterns and sequence analysis of the RV-4 variants revealed that at least four sites on VP7, located at amino acids 94 (region A), 147 to 148 (region B), 213 (region C), and 291, are involved in neutralization of the human G1 rotavirus RV-4. The A-region site elicited antibody cross-reactive between G types and showed species-restricted immunodominance not related to carbohydrate attachment. The monotype 1b rotavirus M37 lacked this site. The B region contained strain-specific and cross-reactive sites, absent in monotype 1c rotaviruses. The C-region site was present in all G1 rotaviruses tested. Monotype 1a rotaviruses contained all these sites of neutralization. Virus monotype and sensitivity to monoclonal antibody neutralization usually related to the presence of a particular amino acid(s) at or next to the positions at which the mutations were selected in the virus variants.
Similar articles
-
Analysis of the neutralization epitopes on human rotavirus VP7 recognized by monotype-specific monoclonal antibodies.J Gen Virol. 1991 Aug;72 ( Pt 8):1855-61. doi: 10.1099/0022-1317-72-8-1855. J Gen Virol. 1991. PMID: 1714939
-
Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7.Virology. 1995 May 10;209(1):80-9. doi: 10.1006/viro.1995.1232. Virology. 1995. PMID: 7747487
-
Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses.J Gen Virol. 1994 Aug;75 ( Pt 8):1867-73. doi: 10.1099/0022-1317-75-8-1867. J Gen Virol. 1994. PMID: 7519247
-
Genetic and antigenic variation of capsid protein VP7 of serotype G1 human rotavirus isolates.J Gen Virol. 1999 Feb;80 ( Pt 2):341-344. doi: 10.1099/0022-1317-80-2-341. J Gen Virol. 1999. PMID: 10073693
-
VP4 and VP7 typing using monoclonal antibodies.Arch Virol Suppl. 1996;12:113-8. doi: 10.1007/978-3-7091-6553-9_13. Arch Virol Suppl. 1996. PMID: 9015108 Review.
Cited by
-
Longitudinal studies of neutralizing antibody responses to rotavirus in stools and sera of children following severe rotavirus gastroenteritis.Clin Diagn Lab Immunol. 1998 Nov;5(6):897-901. doi: 10.1128/CDLI.5.6.897-901.1998. Clin Diagn Lab Immunol. 1998. PMID: 9801354 Free PMC article.
-
Vaccinomics Approach for Multi-Epitope Vaccine Design against Group A Rotavirus Using VP4 and VP7 Proteins.Vaccines (Basel). 2023 Mar 24;11(4):726. doi: 10.3390/vaccines11040726. Vaccines (Basel). 2023. PMID: 37112638 Free PMC article.
-
Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.J Clin Invest. 2019 Aug 12;129(9):3839-3851. doi: 10.1172/JCI128382. eCollection 2019 Aug 12. J Clin Invest. 2019. PMID: 31403468 Free PMC article.
-
Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset.J Virol. 2007 Jun;81(12):6446-58. doi: 10.1128/JVI.00205-07. Epub 2007 Apr 11. J Virol. 2007. PMID: 17428851 Free PMC article.
-
Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.Arch Virol. 1996;141(11):2057-76. doi: 10.1007/BF01718215. Arch Virol. 1996. PMID: 8973523 Clinical Trial.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources